This book investigates how global health innovation systems can be restructured to better address the needs of developing nations while balancing intellectual property rights and public access. Padmashree Gehl Sampath, an expert in technology and development, utilizes a framework rooted in institutional economics to analyze the current landscape of pharmaceutical research and development. She argues that the existing global framework often fails to incentivize the creation of medicines for neglected diseases, proposing instead a more inclusive model that integrates local production capabilities with international policy reform. The text synthesizes empirical data on patent law, trade agreements, and public-private partnerships to build a case for systemic change.

Experts in international development and health policy recognize this work as a rigorous examination of the intersection between trade law and medical innovation. Readers frequently note the academic density of the prose, which serves as a foundational text for those studying the political economy of global health.